EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 68 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,278,000 | +61.9% | 89,729 | -10.0% | 0.09% | +60.3% |
| Q2 2016 | $3,878,000 | -5.3% | 99,664 | -5.0% | 0.06% | -3.3% |
| Q1 2016 | $4,097,000 | -54.3% | 104,911 | +6.5% | 0.06% | -55.2% |
| Q4 2015 | $8,959,000 | +30.2% | 98,502 | +5.8% | 0.13% | +27.6% |
| Q3 2015 | $6,880,000 | -21.8% | 93,141 | -20.2% | 0.10% | -13.9% |
| Q2 2015 | $8,803,000 | +39.8% | 116,758 | -24.9% | 0.12% | +56.4% |
| Q1 2015 | $6,299,000 | – | 155,460 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |